IP Library Granted Patent US 10,471,274
Granted Patent B2
US 10,471,274 · App. 14/167,113 · Granted Nov 12, 2019

Pulse width modulation control for battery-powered laser device

Inventors: Harvey I-Heng Liu (Fremont, CA); John P. Beale (Mountain View, CA)
Assignee: CHANNEL INVESTMENTS, LLC
A61N5/0616A61B18/203A61B2017/00057A61B2017/00075A61B2017/00141A61B2017/00159A61B2017/00734A61B2017/00761A61B2017/00765A61B2017/00769A61B2018/0047A61B2018/00452A61B2018/00476A61B2018/00642A61B2018/00773A61B2018/00791A61B2018/2261A61B2090/065
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,471,274
App. No.
14/167,113
Granted
Nov 12, 2019
Kind
B2
Abstract

A battery-powered laser-based dermatological treatment device may include a laser unit comprising at least one laser diode, a battery unit, at least one sensor configured to generate sensor signals, and a laser drive control system including a laser drive circuit comprising the laser unit, the battery unit, a first switch (e.g., a first FET), and a second switch (e.g., a second FET), wherein the laser unit is arranged in series between the first switch and the second switch, and control electronics configured to control the first switch based at least on sensor signals from the at least one sensor, and control the second switch using pulse width modulation (PWM), thereby delivering current from the battery unit to the laser unit with a PWM current waveform. The laser drive circuit may also include a snubber circuit configured to prevent voltage spikes upon the second switch being turned off.

Claims (43)

1. A dermatological treatment device, comprising:

a laser unit comprising at least one laser diode configured to emit laser radiation at a wavelength between 1400 nm and 2000 nm, suitable for non-ablative fractional photothermolysis;

a battery unit;

at least one sensor configured to generate sensor signals;

an application end configured to be manually moved across a surface of a user's skin during delivery of laser radiation emitted by the laser unit;

a laser control system, comprising:

a laser drive circuit comprising the laser unit, the battery unit, a first switch, and a second switch;

wherein the laser unit is arranged in series between the first switch and the second switch;

control electronics comprising computer instructions stored in non-transitory computer-readable media and executable by a processor to control the laser unit during manual movement of the application end across the surface of the user's skin, to provide a fractional photothermolysis treatment in the skin by generating a sequential series of discrete, non-continuous wave (non-CW) treatment pulses at the wavelength between 1400 nm and 2000 nm delivered to the skin to form a sequential series of non-ablative treatment spots spaced apart from each other on the skin by:

controlling the first switch based at least on sensor signals from the at least one sensor;

controlling the second switch using multi-level pulsing control signals including:

(a) treatment pulse control signals defining at least one pulse characteristic for each of the sequential series of discrete, non-CW treatment pulses, each treatment pulse having a treatment pulse duration in a range between 0.5 ms and 10 ms and producing a corresponding non-ablative treatment spot on the skin, and

(b) pulse width modulation (PWM) control signals that define a PWM waveform within each of the discrete, non-CW treatment pulses, thereby delivering current from the battery unit to the laser unit with a PWM current waveform during each treatment pulse,

wherein the PWM current waveform for each treatment pulse includes a series of multiple PWM pulses that forms a single treatment spot in the skin that is spaced apart from other treatment spots formed by other treatment pulses by non-treated areas of skin, to thereby provide the fractional photothermolysis treatment in the skin.

2. The dermatological treatment device according to claim 1 , wherein the first switch is a first field effect transistor (FET) and the second switch is a second FET.

3. The dermatological treatment device according to claim 1 , wherein the laser drive circuit is free from filtering electronics.

4. The dermatological treatment device according to claim 1 , wherein the control electronics are configured to control the second switch using PWM such that a temperature of the battery unit is increased and maintained within a temperature range of 40-70° C.

5. The dermatological treatment device according to claim 1 , wherein the laser drive circuit further comprises a snubber circuit configured to prevent the occurrence of voltage spikes upon the second switch being turned off.

6. The dermatological treatment device according to claim 1 , wherein the control electronics are configured to automatically control at least one of a frequency or a duty cycle of the PWM current waveform based on a user selected setting.

7. The dermatological treatment device according to claim 1 , wherein the control electronics are configured to dynamically adjust at least one of a frequency or a duty cycle of the PWM current waveform for a particular treatment pulse in real time during the particular treatment pulse.

8. A control system for a dermatological treatment device including a laser unit comprising at least one laser diode configured to emit laser radiation at a wavelength between 1400 nm and 2000 nm, suitable for non-ablative fractional photothermolysis, a battery unit, and at least one sensor configured to generate sensor signals, the control system comprising:

a laser drive circuit comprising the laser unit, the battery unit, a first switch, and a second switch;

wherein the laser unit is arranged in series between the first switch and the second switch;

control electronics configured to control the laser unit, during manual movement of the dermatological treatment device across the surface of the user's skin, to generate a sequential series of discrete, non-continuous wave (non-CW) treatment pulses at the wavelength between 1400 nm and 2000 nm and delivered to a user's skin to form a sequential series of non-ablative treatment spots spaced apart from each other on the skin by:

controlling the first switch based at least on sensor signals from the at least one sensor;

controlling the second switch using multi-level pulsing control signals including:

(a) treatment pulse control signals defining at least one pulse characteristic for each of the sequential series of discrete, non-CW treatment pulses at the wavelength between 1400 nm and 2000 nm suitable for non-ablative fractional photothermolysis, each treatment pulse having a treatment pulse duration in a range between 0.5 ms and 10 ms and producing a corresponding non-ablative treatment spot on the skin, and

(b) pulse width modulation (PWM) control signals that define a PWM waveform within each of the discrete, non-CW treatment pulses, thereby delivering current from the battery unit to the laser unit with a PWM current waveform during each treatment pulse,

wherein the PWM current waveform for each treatment pulse includes a series of multiple PWM pulses that forms a single treatment spot in the skin that is spaced apart from other treatment spots formed by other treatment pulses by non-treated areas of skin, to thereby provide a fractional photothermolysis treatment in the skin.

9. The control system according to claim 8 , wherein the first switch is a first field effect transistor (FET) and the second switch is a second FET.

10. The control system according to claim 8 , wherein the laser drive circuit is free from filtering electronics.

11. The control system according to claim 8 , wherein the control electronics are configured to control the second switch using PWM such that a temperature of the battery unit is increased and maintained within a temperature range of 40-70° C.

12. The control system according to claim 8 , wherein the laser drive circuit further comprises a snubber circuit configured to prevent the occurrence of voltage spikes upon the second switch being turned off.

13. The control system according to claim 8 , wherein the control electronics are configured to automatically control at least one of a frequency or a duty cycle of the PWM current waveform based on a user selected setting.

14. The control system according to claim 8 , wherein the control electronics are configured to dynamically adjust at least one of a frequency or a duty cycle of the PWM current waveform for a particular treatment pulse in real time during the particular treatment pulse.

15. A control system for a dermatological treatment device including a laser unit comprising at least one laser diode, a battery unit, and at least one sensor configured to generate sensor signals, the control system comprising:

a laser drive circuit comprising the laser unit, the battery unit, a first switch, and a second switch;

wherein the laser unit is arranged in series between the first switch and the second switch; and

control electronics configured to:

control the first switch based at least on sensor signals from the at least one sensor; and

control the second switch using pulse width modulation (PWM) during each of a series of discrete, non-continuous wave (non-CW) treatment pulses, each treatment pulse having a treatment pulse duration in a range between 1 ms and 700 ms, thereby delivering current from the battery unit to the laser unit with a PWM current waveform during each treatment pulse, wherein the PWM current waveform for each treatment pulse includes a series of multiple PWM pulses within the respective treatment pulse;

receive sensor signals generated by the at least one sensor based on an interaction with a user's skin; and dynamically adjust at least one waveform profile parameter of the PWM current waveform for a particular treatment pulse in real time during the particular treatment pulse based on the received sensor signals.

16. The control system according to claim 15 , wherein dynamically adjusting at least one waveform profile parameter of the PWM current waveform for a particular treatment pulse in real time during the particular treatment pulse comprises dynamically adjusting at least one of a frequency or a duty cycle of the PWM current waveform for the particular treatment pulse in real time during the particular treatment pulse.

Assignments (4)
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER FOR ONE PATENT IDENTIFIED IN THE DEED OF ASSIGNMENT. ONE PATENT ON THE TOP OF PAGE 3 WAS IDENTIFIED INCORRECTLY (THE CORRECT PATENT NUMBER IS 9687671, NOT 9687651). THE AMENDED DEED OF ASSIGNMENT CORRECTS THIS ERROR. ALSO ATTACHED TO THIS CORRECTIVE ASSIGNMENT IS THE PREVIOUSLY RECORDED COVER SHEET CONTAINING THE ERROR, PREVIOUSLY RECORDED ON REEL 72121 FRAME 256. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT OF ASSIGNOR'S INTEREST. Recorded Oct 20, 2025
From: CHANNEL INVESTMENTS, LLC
To: AESTHETE HOLDING CORPORATION
Reel/Frame 073686/0429 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2025
From: CHANNEL INVESTMENTS, LLC
To: AESTHETE HOLDING CORPORATION
Reel/Frame 072121/0256 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2017
From: TRIA BEAUTY, INC.
To: CHANNEL INVESTMENTS, LLC
Reel/Frame 042229/0195 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 30, 2017
From: LIU, HARVEY I-HENG; BEALE, JOHN P.
To: TRIA BEAUTY, INC.
Reel/Frame 041800/0647 →
Continuity (2)
Provisional Application 61758609 · Jan 30, 2013
Related Publication 20140214136A1 · Jul 31, 2014
Cited By (9)
US 1,065,551 US 1,084,369 US 1,112,778 US 1,116,120 US 1,141,134 US 12,186,513 US 12,295,618 US 12,478,771 US 12,544,051